Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
31059 | 128 | 27.7 | 30% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1571 | 6700 | LEPROSY REVIEW//INTERNATIONAL JOURNAL OF LEPROSY AND OTHER MYCOBACTERIAL DISEASES//LEPROSY |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | SI PHARMACOL TOXICOL | Address | 4 | 75% | 2% | 3 |
2 | MICRONUCLEI INDUCED | Author keyword | 2 | 67% | 2% | 2 |
3 | TUBERCULOSIS CHEMOTHERAPY | Author keyword | 1 | 40% | 2% | 2 |
4 | AUREOFUNGIN | Author keyword | 1 | 50% | 1% | 1 |
5 | DOMINANT LETHAL MUTATIONS INDUCED | Author keyword | 1 | 50% | 1% | 1 |
6 | ROVAMYCIN | Author keyword | 1 | 50% | 1% | 1 |
7 | WP2 MUTAGENICITY TEST | Author keyword | 0 | 33% | 1% | 1 |
8 | MODULATORY EFFECTS | Author keyword | 0 | 25% | 1% | 1 |
9 | POLYADP RIBOSE POLYMERASE INHIBITION | Author keyword | 0 | 20% | 1% | 1 |
10 | BOTUCATU MED UNESP | Address | 0 | 11% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CLASTOGENIC FACTOR | 1 | 33% | 2% | 2 |
2 | ANTILEPROSY DRUG | 1 | 50% | 1% | 1 |
3 | DIIODOHYDROXYQUINOLINE | 1 | 50% | 1% | 1 |
4 | SHORT TERM CHEMOTHERAPY | 1 | 22% | 2% | 2 |
5 | BLOOD LYMPHOCYTE CULTURES | 0 | 33% | 1% | 1 |
6 | LEPROSY SERUM | 0 | 100% | 1% | 1 |
7 | UNTREATED LEPROSY PATIENTS | 0 | 100% | 1% | 1 |
8 | UNTREATED TUBERCULOSIS PATIENTS | 0 | 100% | 1% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
GENOTOXIC EFFECTS OF MYCOBACTERIUM-LEPRAE INFECTION IN HUMANS | 1994 | 7 | 44 | 30% |
DRUG-INDUCED CHROMOSOME-DAMAGE | 1985 | 4 | 26 | 19% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SI PHARMACOL TOXICOL | 4 | 75% | 2.3% | 3 |
2 | BOTUCATU MED UNESP | 0 | 11% | 0.8% | 1 |
3 | SERV VIXILANCIA SAUDE | 0 | 100% | 0.8% | 1 |
4 | SI MOL BIOL GENET | 0 | 100% | 0.8% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000205770 | DUNN OSTEOSARCOMA//PROCARBAZINE//DNA IRONIII COMPLEX |
2 | 0.0000175412 | CYTOKINE BIOL SIGNAL TRANSDUCT//MICROGLIAL INFLAMMATION//MOUTH CLEANING |
3 | 0.0000160455 | SISTER CHROMATID EXCHANGE//SISTER CHROMATID EXCHANGES//HIGH FREQUENCY CELL |
4 | 0.0000151376 | LEPROSY LEPROMATOUS//LEPROSY BORDERLINE//PHARM CLIN ANAL |
5 | 0.0000138747 | CLOFAZIMINE//B669//RIMINOPHENAZINES |
6 | 0.0000126259 | DPTO CITOL HISTOL NORMAL PATOL//4 METHYLTHIOAMPHETAMINE 4 MTA//ALDOMET |
7 | 0.0000113965 | INTERNATIONAL JOURNAL OF LEPROSY AND OTHER MYCOBACTERIAL DISEASES//DERMATOL LEPROL//M LEPRAE ANTIGEN |
8 | 0.0000111275 | ALPHA TOCOPHEROL THERAPY//COMBINATION PATHOGENETIC THERAPY//GRP DEV MOL DIAGNOST IN IDUALIZED THER Y |
9 | 0.0000101500 | CHLOROPHYLLIN//SODIUM COPPER CHLOROPHYLLIN//INTERCEPTOR MOLECULES |
10 | 0.0000088995 | PHENAZOPYRIDINE HYDROCHLORIDE//PHENAZOPYRIDINE//2 3 6 TRIAMINOPYRIDINE |